- Home
- THFF vs SLBT Comparison
THFF vs SLBT Comparison
Compare THFF & SLBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | THFF | SLBT |
|---|---|---|
| Founded | 1984 | N/A |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Major Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 881.8M | 846.7M |
| IPO Year | 1995 | 2025 |
Fundamental Metrics
Financial Performance| Metric | THFF | SLBT |
|---|---|---|
| Price | $74.76 | $1.52 |
| Analyst Decision | Hold | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $85.33 | N/A |
| AVG Volume (30 Days) | ★ 92.9K | 67.6K |
| Earning Date | 10-30-2026 | N/A |
| Dividend Yield | ★ 3.03% | N/A |
| EPS Growth | ★ 67.00 | N/A |
| EPS | ★ 3.58 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.88 | N/A |
| Revenue Next Year | $16.04 | N/A |
| P/E Ratio | $20.59 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $52.45 | $1.42 |
| 52 Week High | $84.17 | $6.25 |
Technical Indicators
Market Signals| Indicator | THFF | SLBT |
|---|---|---|
| Relative Strength Index (RSI) | 41.92 | 36.42 |
| Support Level | $71.68 | $1.44 |
| Resistance Level | $75.61 | $1.98 |
| Average True Range (ATR) | 1.35 | 0.11 |
| MACD | 0.13 | 0.04 |
| Stochastic Oscillator | 52.77 | 19.51 |
Price Performance
Historical ComparisonAbout THFF First Financial Corporation Indiana
First Financial Corp operates as a financial holding company, which is engaged in the provision of financial services in the United States. The company offers a wide variety of financial services including commercial, mortgage, and consumer lending, lease financing, trust account services, depositor services and insurance services, through its subsidiaries. Its primary source of revenue is derived from loans to customers and investment activities. Company's loan portfolio was diversified in Commercial, Residential and consumer domains.
About SLBT SL Science Holding Limited Ordinary Shares
SL Science Holding Ltd is a biomedical company specialized in developing cellular and gene therapies advancing regenerative medicine and cancer treatment. It utilizes immune stem cells to target cancer and bovine-derived milk exosomes to regenerate damaged tissues, thus potentially offering expansive medical applications for its products. With proprietary technologies such as Armed-T and Gamma Delta T cells, as well as exosome applications in skincare and cancer recovery. It operates in three segments namely Exosome products, CD-19 Armed-T products, and GDT cell therapy products. It derives revenue from Exosome products segment.